Sponsored

Result Summary for Survey:Prophylaxis and Management of Arrhythmias After Thoracic Surgery

Prophylaxis and Management of Arrhythmias After Thoracic Surgery

This survey was designed to help inform readers about current practices in prophylaxis
for and management of supraventricular arrhythmias after major thoracic surgery.
Participants were asked to respond to questions regarding perioperative management
of thoracic surgery patients. They were asked to assume that their patients had
no history of cardiac arrhythmia and were undergoing esophagectomy or major lung
resection. 

The incidence of such arrhythmias was 10% to 20% in most practices, which is similar
to what is reported in the current literature. Twenty percent of surgeons used
prophylaxis routinely, most commonly a beta blocker, and half the surgeons never
used prophylaxis. A variety of drugs were used to treat SVT when it developed,
including, in descending order of frequency, amiodarone, beta blockers, digoxin,
and calcium channel blockers. 

Interestingly, the vast majority of surgeons treated the arrhythmias themselves.
Just under two thirds of respondents indicated that a cardiologist became involved
in the treatment of these arrhythmias less than 20% of the time, indicating that
the treatments provided by surgeons were generally successful.

1. What is the incidence of postoperative
supraventricular arrhythmias in such patients in your practice?
  Response
Percent
Response
Count
10%
37.8% 70
20%
36.2% 67
30%
20.5% 38
40% or more
5.4% 10
  answered question 185
 
skipped question
0
2. Do you use pharmacologic prophylaxis in
this patient population?
  Response
Percent
Response
Count
Yes, routinely
18.4% 34
Yes, only in selected patients
34.6% 64
No
47.0% 87
  answered question 185
 
skipped question
0
3. Please check all drugs you normally use
for prophylaxis.
  Response
Percent
Response
Count
Digoxin
28.3% 32
Beta blocker
77.9% 88
Calcium channel blocker
16.8% 19
  answered question 113
 
skipped question
72
4. Please check all drugs you normally use
for treatment.
  Response
Percent
Response
Count
Digoxin
40.2% 72
Beta Blocker
60.9% 109
Calcium channel blocker
37.4% 67
Adenosine
4.5% 8
Amiodarone
79.3% 142
  answered question 179
 
skipped question
6
5. When a patient develops a postoperative
supraventricular arrhythmia, who initially manages this problem?
  Response
Percent
Response
Count
Treating surgeon
76.8% 142
Intensive care specialist
11.4% 21
Primary care physician
0.5% 1
Cardiologist
11.4% 21
  answered question 185
 
skipped question
0
6. In what percentage of patients who develop
supraventricular arrhythmia does a cardiologist become involved in
therapy?
  Response
Percent
Response
Count
10%
41.6% 77
20%
18.9% 35
30%
13.5% 25
40% or more
25.9% 48
  answered question 185
 
skipped question
0
7. In what region is your surgical practice
based?
  Response
Percent
Response
Count
North America
44.3% 82
Europe
38.4% 71
South America
4.9% 9
Asia
9.7% 18
Africa
2.7% 5
  answered question 185
 
skipped question
0

Prophylaxis and Management of Arrhythmias After Thoracic Surgery

This survey was designed to help inform readers about current practices in prophylaxis
for and management of supraventricular arrhythmias after major thoracic surgery.
Participants were asked to respond to questions regarding perioperative management
of thoracic surgery patients. They were asked to assume that their patients had
no history of cardiac arrhythmia and were undergoing esophagectomy or major lung
resection. 

The incidence of such arrhythmias was 10% to 20% in most practices, which is similar
to what is reported in the current literature. Twenty percent of surgeons used
prophylaxis routinely, most commonly a beta blocker, and half the surgeons never
used prophylaxis. A variety of drugs were used to treat SVT when it developed,
including, in descending order of frequency, amiodarone, beta blockers, digoxin,
and calcium channel blockers. 

Interestingly, the vast majority of surgeons treated the arrhythmias themselves.
Just under two thirds of respondents indicated that a cardiologist became involved
in the treatment of these arrhythmias less than 20% of the time, indicating that
the treatments provided by surgeons were generally successful.

1. What is the incidence of postoperative
supraventricular arrhythmias in such patients in your practice?
  Response
Percent
Response
Count
10%
37.8% 70
20%
36.2% 67
30%
20.5% 38
40% or more
5.4% 10
  answered question 185
 
skipped question
0
2. Do you use pharmacologic prophylaxis in
this patient population?
  Response
Percent
Response
Count
Yes, routinely
18.4% 34
Yes, only in selected patients
34.6% 64
No
47.0% 87
  answered question 185
 
skipped question
0
3. Please check all drugs you normally use
for prophylaxis.
  Response
Percent
Response
Count
Digoxin
28.3% 32
Beta blocker
77.9% 88
Calcium channel blocker
16.8% 19
  answered question 113
 
skipped question
72
4. Please check all drugs you normally use
for treatment.
  Response
Percent
Response
Count
Digoxin
40.2% 72
Beta Blocker
60.9% 109
Calcium channel blocker
37.4% 67
Adenosine
4.5% 8
Amiodarone
79.3% 142
  answered question 179
 
skipped question
6
5. When a patient develops a postoperative
supraventricular arrhythmia, who initially manages this problem?
  Response
Percent
Response
Count
Treating surgeon
76.8% 142
Intensive care specialist
11.4% 21
Primary care physician
0.5% 1
Cardiologist
11.4% 21
  answered question 185
 
skipped question
0
6. In what percentage of patients who develop
supraventricular arrhythmia does a cardiologist become involved in
therapy?
  Response
Percent
Response
Count
10%
41.6% 77
20%
18.9% 35
30%
13.5% 25
40% or more
25.9% 48
  answered question 185
 
skipped question
0
7. In what region is your surgical practice
based?
  Response
Percent
Response
Count
North America
44.3% 82
Europe
38.4% 71
South America
4.9% 9
Asia
9.7% 18
Africa
2.7% 5
  answered question 185
 
skipped question
0
0 comments

Leave a Reply

Log In

New to CTSNet? Sign Up